News Release

 

Back
 

Memorial Sloan-Kettering Signs Agreement for AmerisourceBergen Technology Group's Bridge-MedPoint Patient Safety Solution

11/29/04

Memorial Sloan-Kettering Signs Agreement for AmerisourceBergen Technology Group's Bridge-MedPoint Patient Safety Solution

Valley Forge, Pa. November 29, 2004 - AmerisourceBergen Technology Group today announced that Memorial Sloan-Kettering Cancer Center has signed an agreement to install the full suite of Bridge-MedPoint point-of-care medication verification, specimen identification, and transfusion verification patient safety solutions. The Bridge-MedPoint system has been shown to enhance patient safety by reducing the potential for point-of-care medical errors thereby lowering the cost of care, improving patient outcomes and fostering higher job satisfaction of nursing staff who view Bridge-MedPoint¡¦s automated double-checks as insurance against mishaps.

"Because patient safety is one of our top priorities, the Bridge-MedPoint software applications will add another checkpoint at the point of care to our existing practices,¨ said Patricia Skarulis, Vice President, Information Services and Chief Information Officer, Memorial Sloan-Kettering Cancer Center. "In addition, its data analysis feature will allow us to collect and analyze information that will be useful in many areas.¨

"We look forward to partnering with Memorial Sloan-Kettering to achieve world class excellence in oncology care. As the world's leading cancer institute, Memorial Sloan-Kettering is setting the bar for hospitals across the country by using Bridge-MedPoint technology to improve patient outcomes,¨ commented Denean Rivera, president of AmerisourceBergen Technology Group's Bridge Medical product line.

Bridge-MedPoint is a suite of cost-effective solutions designed to assist hospital staff in improving patient safety at the bedside and providing meaningful information for process improvement. Bridge-MedPoint uses bar-code technology and point-of-care computing devices to verify the five rights, alert nurses to look-alike and sound-alike medications, as well as high-risk medications, provide age and weight-based dosing parameters for sensitive pediatric and geriatric patients, offer medication allergy checks and to check many other essential clinical rules. In addition, Bridge-MedPoint capabilities integrate well with nursing operations to enhance the nursing experience with the patient.

About AmerisourceBergen
AmerisourceBergen„¥ (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, physician¡¦s offices, alternate care and mail order facilities, independent community pharmacies, and regional chain pharmacies. Through its AmerisourceBergen Technology Group, the company is a leading provider of point-of-care patient safety solutions and has been honored for its educational initiatives and patient safety solutions. With more than $48 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 14,000 people. AmerisourceBergen is ranked #22 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

Contact:
Barbara Brungess
610-727-7199
bbrungess@amerisourcebergen.com

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More